Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19 And Fatty Liver Disease  Sep 04, 2020  3 years, 7 months, 2 weeks, 18 hours, 52 minutes ago

Fatty-Liver Disease Increases Risk Of COVID-19 Hospitalization But Majority Do Not Even Know They Have Fatty Liver Disease

Fatty-Liver Disease Increases Risk Of COVID-19 Hospitalization But Majority Do Not Even Know They Have Fatty Liver Disease
Source: COVID-19 And Fatty Liver Disease  Sep 04, 2020  3 years, 7 months, 2 weeks, 18 hours, 52 minutes ago
COVID-19 And Fatty Liver Disease: Researchers from the University of Minnesota and John Hopkins School of Medicine in a new observational study reveal that individuals with non-alcoholic fatty liver disease and steatohepatitis have increased odds of hospitalization due to coronavirus disease (COVID-19); conversely, metabolic surgery was found to be protective against the admission of infected individuals.


 
It should be noted that roughly 1 out of 4 individuals globally suffer from some sort of fatty liver disease. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909941/
 
However most people are unaware of the fact that they have the disease due to the lack of symptoms during the initial phases of the disease.
 
The study showing the correlation between fatty-live disease and COVID-19 hospitalization was published on a preprint server and is yet to be peer-reviewed. https://www.medrxiv.org/content/10.1101/2020.09.01.20185850v1
 
To date we already know the most critical risk groups for severe clinical presentations are the elderly, those living with diabetes, and those with other chronic conditions (such as heart and lung disease).
 
Interestingly hepatic steatosis (comprising non-alcoholic fatty liver disease and non-alcohol steatohepatitis) correlates well with visceral adiposity, developed metabolic disease, as well as overt and chronic inflammation process.
 
Considering that COVID-19's pathophysiology is tightly linked to inflammation, non-alcoholic fatty liver disease and steatohepatitis may also represent significant risk factors that put patients with the disease at higher risk of poor disease outcomes; nonetheless, the research on this and possible mitigating factors has been scarce.
 
Hence this is why the study team sought to appraise the risk of hospitalization for COVID-19 associated with non-alcoholic fatty liver disease and steatohepatitis.
 
This resea